- Home
- SDOT vs ABVC Comparison
SDOT vs ABVC Comparison
Compare SDOT & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SDOT | ABVC |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1M | 26.1M |
| IPO Year | 2019 | 2009 |
Fundamental Metrics
Financial Performance| Metric | SDOT | ABVC |
|---|---|---|
| Price | $7.26 | $1.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.5K | ★ 58.8K |
| Earning Date | 11-18-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 490.91 | 7.14 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,929,137.00 | $509,589.00 |
| Revenue This Year | $201.80 | N/A |
| Revenue Next Year | N/A | $171.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 60.08 | N/A |
| 52 Week Low | $0.01 | $0.71 |
| 52 Week High | $12.85 | $3.06 |
Technical Indicators
Market Signals| Indicator | SDOT | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 40.56 | 54.70 |
| Support Level | $0.27 | $1.00 |
| Resistance Level | $12.56 | $1.14 |
| Average True Range (ATR) | 0.64 | 0.06 |
| MACD | -0.48 | 0.00 |
| Stochastic Oscillator | 2.00 | 89.94 |
Price Performance
Historical ComparisonAbout SDOT Sadot Group Inc.
Sadot Group Inc consisted of one distinct operating unit engaged in the Agri-Foods industry. Its operating unit was intended to be a Agri-Foods company engaged in farming, commodity trading and shipping of food and feed (e.g., soybean meal, wheat and corn) via dry bulk cargo ships across the globe.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.